Trial
NCT03953209
Spironolactone for the Treatment of Melasma
Phase IWITHDRAWNOPERATIONALConfidence: HIGH
Sponsor
Medical University of South Carolina
Collaborators
—
Condition
Melasma
Intervention
Spironolactone 50Mg Tablet
Why stopped
Conflict with funding
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2024-09-04